Comparison of the levels of tumor necrosis factor-α and interleukin-17 in gingival crevicular fluid of patients with peri-implantitis and a control group with healthy implants

Iranian Journal of Allergy, Asthma and Immunology

Volumn 12, Issue 1, 2013, Pages 75-80

  Darabi, Ehsan ^a   Kadkhoda, Zeinab ^a   Amirzargar, Aliakbar ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

IL 17; Implant; Peri implantitis; TNF

Indexed keywords

INTERLEUKIN 17; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVITIS; HUMAN; MALE; PERIIMPLANTITIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

ADULT; CASE-CONTROL STUDIES; DENTAL IMPLANTS; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; INTERLEUKIN-17; MALE; MIDDLE AGED; PERI-IMPLANTITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84875543570     PISSN: 17351502     EISSN: 17355249     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Andreiotelli M, Koutayas SO, Madianos PN, Strub JR. Relationship between interleukin-1 genotype and periimplantitis: a literature review. Quintessence Int 2008; 39(4):289-98.
2. Troen BR. Molecular mechanisms underlying osteoclast formation and activation. Exp Gerontol 2003; 38: 605-14. (Pubitemid 36694163)
3. Boyce BF, Li P, Yao Z, Zhang Q, Badell IR, Echwarz EM, et al. TNF-alpha and pathologic bone resorption. Keio J Med 2005; 54(3):127-31.
4. Seymour GJ, Gemmell E. Cytokines in periodontal disease: Where to from here? Acta Odontol Scand 2001; 59:167-73. (Pubitemid 33644366)
5. Petkovic-Curcin A, Matic S, Vojvodic D, Stamatovic N, Todorovic T. Cytokines in pathogenesis of periimplantitis. Vojnosaniti Pregl 2004, 68(5): 435-40.
6. Esposito M, Hirsch J, Lekholm U, Thomsen P. Differential diagnosis and treatment strategies for biologic complications and failing oral implants: a review of the literature. Int J Oral Maxillofac Implants 1999; 14(4):473-490.
7. Mombelli A, Lang NP. The diagnosis and treatment of peri-implantitis. Periodontol 1998; 17:63-76. (Pubitemid 128556018)
8. Panagakos FS, Aboyoussef H, Dondero R, Jandinski JJ. Detection and measurement of inflammatory cytokines in implant crevicular fluid: a pilot study. Int J Oral Maxillofac Implants 1996; 11(6):794-9. (Pubitemid 126442788)
9. Bartold PM, Narayana AS. Biology of the periodontal connective tissue. 1st ed. Chicago: Quintessence publishing, 1998. Chap-10.
10. Page RC. Host response test for diagnosis periodontal diseases. J periodontol 1992; 63:356-66.
11. Goodson JM, Haffajee AD, Socransky SS. The relationship between attachment level loss and alveolar boneless. J clin periodontol 1984; 11(5):384-59.
12. Greenstein G, Caton J. periodontal diseases activity: a critical assessment. J periodontol 1990; 61(9):543-62.
13. Embery G, Waddington R. Gingival crevicular fluid: biomarkers of periodontal tissue activity. Adv Dent Res 1994; 8(2):329-31.
14. Adongianaki E, Mgoney J, Kinane DF. The ability of gingival crevicular fluid acute phase proteins to distinguish healthy, gingivitis and periodontitis sites. J clin periodontol 1992; 19(2):98-102.
15. Arnold R, Lunstad G, Bissada N, Stallard R. Alternations in crevicular fluid flow during healing following gingival surgery. J Periondontal Res 1996; 1(4):303-11.
16. Delima AJ, Oates T, Assuma R, Schwartz Z, Cochran D, Amar S, Graves DT. A soluble antagonist to IL-1 and TNF inhibits loss of tissue attachment in experimental periodontitis. J clin periodontol 2001; 28(3):233-40. (Pubitemid 33755189)
17. Graves DT, Cochran D. The contribution of IL-1 and TNF to periodontal tissue destruction. J periodontol 2003; 74(3):391-401. (Pubitemid 36939356)
18. Hamdy AA, Ebrahem MA. The Effect of Interleukin-1 Allele 2 Genotype (IL-1a (-889) and IL-1b (+3954)) on the Individual's Susceptibility to Peri-Implantitis: Case-Control Study. J Oral Implantol 2011; 37(3):325-34.
19. Laine ML, Leonhardt A, Roos-Jansaker AM, Pena AS, van Winkelhoff AJ, Winkel EG, et al. IL-1RN gene polymorphism is associated with peri-implantitis. Clin Oral Implants Res 2006; 17(4):380-5. (Pubitemid 44114702)
20. Huynh-Ba G, Lang NP, Tonetti MS, Zwahlen M, Salvi GE. Association of the composite IL-1 genotype with peri-implantitis: a systematic review. Clin Oral Implants Res 2008; 19(11):1154-62.
21. Wilson TG Jr, Nunn M. The relationship between the interleukin-1 periodontal genotype and implant loss. Initial data. J Periodontol 1999; 70(7):724-9.
22. Greenstein G, Hart TC. Clinical utility of a genetic susceptibility test for severe chronic periodontitis: a critical evaluation. J Am Dent Assoc 2002; 133(4):452-9.
23. Lachmann S, Kimmerle-Müller E, Axmann D, Scheideler L, Weber H, Haas R. Associations between peri-implant crevicular fluid volume, concentrations of crevicular inflammatory mediators, and composite IL-1A -889 and IL-1B +3954 genotype. A cross-sectional study on implant recalls patients with and without clinical signs of peri-implantitis. Clin Oral Implants Res 2007; 18(2):212-23.
24. Melo RF, Lopes BM, Shibli JA, Marcantonio Junior E, Marcantonio RA, Galli GM. Interleukin-1- and interleukin-6 expression and gene polymorphisms in subjects with peri-implant disease. Clin Implant Dent Relat Res 2011; 17:10.
25. Javed F, Al-Hezaimi K, Salameh Z, Almas K, Romanos GE. Proinflammatory cytokines in the crevicular fluid of patients with peri-implantitis. Cytokine 2011; 53(1):8-12.
26. Ataoglu H, Alptekin NO, Haliloglu S, Gursel M, Ataoglu T, Serpek B, et al. Interleukin-1beta, tumor necrosis factor-alpha levels and neutrophil elastase activity in periimplant crevicular fluid. Clin Oral Implants Res 2002; 13(5):470-6.
27. Liskmann S, Vihalemm T, Salum O, Zilmer K, Fischer K, Zilmer M. Correlations between clinical parameters and interleukin-6 and interleukin-10 levels in saliva from totally edentulous patients with peri-implant disease. Int J Oral Maxillofac Implants 2006; 21(4):543-50. (Pubitemid 44358676)
28. Konttinen YT, Lappalainen R, Laine P, Kitti U, Santavirta S, Teronen O. Immunohistochemical evaluation of inflammatory mediators in failing implants. Int J Periodontics Restorative Dent 2006; 26(2):135-41. (Pubitemid 43592503)
29. Duarte PM, de Mendonca AC, Máximo MB, Santos VR, Bastos MF, Nociti Junior FH. Differential cytokine expressions affect the severity of peri-implant disease. Clin Oral Implants Res 2009; 20(5):514-20.
30. Curtis DA, Kao R, Plesh O, Finzen F, Franz L. Crevicular fluid analysis around two failing dental implants: a clinical report. J Prosthodont 1997; 6(3):210-4. (Pubitemid 127733535)
31. Murata M, Tatsumi J, Kato Y, Suda S, Nunokawa Y, Kobayashi Y, et al. Osteocalcin, deoxypyridinoline and interleukin-1beta in peri-implant crevicular fluid of patients with peri-implantitis. Clin Oral Implants Res 2002; 13(6):637-43. (Pubitemid 41749852)
32. Konttinen YT, Lapplinen R, Laine P, Kitti U, Santavirta S, Teronen O. Immunohistochemical evaluation of inflammatory mediators in failing implants. Int J Periodontics restorative Dent 2006; 26(2):135-41. (Pubitemid 43592503)
33. De mendonca AC, Santos VR, Cesar-Neto JB, Duarte PM. Tumor Necrosis factor-alpha level after surgical anti infective therapy for peri-implantitis: a 12 month follow up; J Periodontal 2009; 80(4):693-9.
34. Duarte PM, De Mendonca AC, Maximom MB, Santos VR, Bastos BF, Nociti FH. Effect of anti infective mechanical therapy on clinical parameters and cytokine levels in human peri implant diseases: J Periodontal 2009; 80(2):234-43.
35. Vernal R, Dutzan N, Chaparro A, Puente J, Antonieta Valenzuela M, Gamonal G. Levels of interleukin-17 in gingival crevicular fluid and in supernatants of cellular cultures of gingival tissue from patients with chronic periodontitis. J Clin Periodontol 2005; 32(4):383-9. (Pubitemid 40569601)
36. Beklen A, Ainola M, Hukkanen M, Gürgan C, Sorsa T, Konttinen YT. MMPs, IL-1, and TNF are regulated by IL-17 in periodontitis. J Dent Res 2007; 86(4):347-51.
37. Severino VO, Napimoga MH, de Lima Pereira SA. Expression of IL-6, IL-10, IL-17 and IL-8 in the periimplant crevicular fluid of patients with peri-implantitis. Arch Oral Biol 2011; 56(8):823-8.
38. Page RC, Kornman KS. The pathogenesis of human periodontitis: An introduction. Periodontol 1997; 14(1):9-11.
39. Zou DR, Zhu H, Qu XH. Detection and measurement of interleukin-8 in peri-implant crevicular fluid. Hua Xi Kou Qiang Yi Xue Za Zhi 2005; 23(4):292-4.
40. Petkovic A. Significance of proinflammatory (IL1-, TNF-, MIP1- i IL8) and peri-implant sulcus fluid [thesis]. Belgrade: Military Medical Academy; 2005. (Serbian)
41. Bostanci N, Ilgenli T, Emingil G, Afacan B, Han B, Toz H, et al. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: Implications of their relative ratio J Clin Periodontol 2007; 34(5):370-76.
42. Konttinen YT, Lappalainen R, Laine P, Kitti U, Santavirta S, Teronen O. Immunohistochemical evaluation of inflammatory mediators in failing implants. Int J Periodontics Restorative Dent 2006; 26(2):135-41. (Pubitemid 43592503)
43. Schenkein HA, Koertge TE, Brooks CN, Sabatini R, Purkall DE, Tew JG. IL-17 in sera from patients with aggressive periodontitis. J Dent Res 2010; 89(9):943-7.